IL-6 and Crohn's Disease

E-ISSN： 1875-5933|2|2|125-130

ISSN： 1568-010X

Source： Current Drug Targets. Inflammation & Allergy, Vol.2, Iss.2, 2003-06, pp. : 125-130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel therapy for Crohn’s disease targeting IL-6 signalling

By Ito Hiroaki

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 4, 2004-08 ,pp. : 287-294

Informa Healthcare

Access to resources Recommend Favorite

IL-10: treatment option for Crohn's disease?

Inpharma, Vol. 1, Iss. 1273, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Macrophage-Derived IL-18 Targeting for the Treatment of Crohn's Disease

Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 2, 2003-06 ,pp. : 131-136

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-IL-12/23 in Crohn's Disease: Bench and Bedside

Current Drug Targets, Vol. 14, Iss. 12, 2013-11 ,pp. : 1379-1384

Bentham Science Publishers

Access to resources Recommend Favorite

Budesonide for Crohn's disease

By Seow Cynthia H Benchimol Eric I Steinhart A Hillary Griffiths Anne M Otley Anthony R

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 8, 2009-08 ,pp. : 971-979

Informa Healthcare

Access to resources Recommend Favorite